Advances in Treating HER2+ Breast Cancer With Brain Metastases
Sarah Sammons, MD, medical oncologist, clinical investigator in the Breast Oncology Center, associate director of the Metastatic Breast Cancer Program, Dana-Farber Cancer Institute, discusses findings from an analysis of the DESTINY-Breast03 trial ( …